Development of a Noninvasive Skin Evaluation Method for Lower Limb Lymphedema
Development of a Noninvasive Skin Evaluation Method for Lower Limb Lymphedema
复制标题
DOI:
10.1089/lrb.2018.0089
复制
发表时间:
2019-06-18
影响因子:
1.4
通讯作者:
Unno, Naoki
中科院分区:
文献类型:
--
作者:
Sano, Masaki;Hirakawa, Satoshi;Unno, Naoki
Background: The skin's condition is altered in lymphedema patients, and evaluating this change is important. Some noninvasive methods for evaluating skin condition have been reported, especially in upper limb lymphedema. However, evaluating the skin in lower limb lymphedema remains challenging and is often limited to palpation. We aimed to develop a noninvasive skin evaluation method for lower limb lymphedema patients. Methods and Results: Twenty-five lower limb lymphedema patients were included. Skin induration and elasticity were measured using Indentometer (R) IDM 400 and Cutometer (R) MPA580. The relationship between the properties of skin from the healthy forearm and thigh, those of the affected thigh, and age was analyzed. Predicted skin induration age (IA) and elasticity age (EA) were calculated from the forearm, whereas actual values were calculated from the thigh, and the differences (Delta IA and Delta EA) were assessed. Patients were classified according to the International Society of Lymphology clinical staging system, and the differences in Delta IA and Delta EA were analyzed among the three groups (healthy, stage I/IIa, and stage IIb/III). Skin biopsy was performed in five unilateral lower limb lymphedema patients, and the dermal elastic fiber area was determined using microscopy with Elastica van Gieson staining. Delta EA significantly increased with disease progression, but Delta IA did not change significantly. Microscopy revealed elastic fiber filamentous changes, with decreased elastic fiber areas in lymphedema-affected skin. Conclusion: To our knowledge, this is the first report to evaluate lower limb skin elasticity in lymphedema quantitatively and noninvasively. Delta EA is useful for evaluating skin condition progression in lymphedema patients.